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Summary. The breast and ovarian cancer susceptibility 
gene BRCAl has been recently cloned and revealed an 
open reading frame of 1863 amino acids, but a lack of 
significant homology to any known protein in the 
database has led to few clues about its functions. One of 
the first steps to investigate the function of BRCAl was 
to define its subcellular localization. Several reports 
have led to contradictory findings that include: nuclear 
localization in normal cells and cytoplasmic in breast 
and ovarian cancer cells; nuclear in both normal and 
cancer cells; cytoplasmic and secreted to the extra- 
cellular space; present in tube-like invaginations of the 
nucleus; and colocalizing with the centrosome. As is 
apparent, the subcellular localization has been the most 
controversial aspect of BRCAl biology and is a key 
point to uncover its functions. In this paper we review 
the published data on subcellular localization of BRCAl 
with special emphasis on the antibodies and techniques 
used. We conclude that there is now overwhelming 
evidence to support a nuclear localization for BRCAl, 
both in normal and cancer cells. In addition, several 
BRCAl-interacting proteins have been isolated and they 
are preferentially located in the nucleus. Evidence 
supporting a physiological function for BRCAl during 
DNA repair and transcriptional activation is also 
discussed. 
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Introduction 
Mutations in BRCAl account for approximately 45% 
of the families with high incidence of breast cancer and 
80% of families with high incidence of both breast and 
ovarian cancer (Easton et al., 1993). Identification of 
human BRCAl by positional cloning techniques revealed 
an open reading frame coding for 1863 amino acids with 
no statistically significant homology to proteins in the 
database, with the exception of a zinc-binding RING 
finger motif (C3HC4) in the N-terminal region (Miki et 
al., 1994). This motif is found in several proteins that 
have their functions mediated through DNA binding 
(Saurin et al., 1996). In addition, the presence of two 
putative nuclear localization signals (NLSs; aa 500-508 
and 609-615) and an excess of negatively charged 
residues in the C-terminal region of BRCAl suggested a 
function for BRCAI in transcriptional regulation (Miki et 
al., 1994). Using a different computational strategy, 
Koonin et al. partitioned the BRCAl sequence into 
putative globular and non-globular domains and used the 
globular domains to perform iterative searches in the 
database (Koonin et al., 1996). These studies defined a 
globular domain repeated in tandem in the C-terminal 
region of BRCAI, named BRCT (for BRCAl C- 
terminal domain) also present in 53BP1, a p53 binding 
protein (Koonin et al., 1996). This study was later 
extended and defined a superfamily of proteins 
containing the BRCT domains involved in DNA damage 
and cell cycle checkpoints (Bork et al., 1997; Callebaut 
and Mornon, 1997). Collectively, the fact that the RING 
finger, the NLSs, the excess of negatively charged 
residues and the BRCT domains are conserved in 
human, dog, rat and mouse Brcal, suggests that these 
regions are significant for BRCAl function (Abel et al., 
1995; Lane et al., 1995; Sharan et al., 1995; Szabo et al., 
1996; Bennet et al., 1999). 
Is BRCAl aberrantly localized in breast and ovarian 
cancer? 
One of the first strategies to understand the bio- 
chemical function of BRCAl was immunofluorescence 








